tat as a biomarker to assess the risk of cancer
TRANSCRIPT
TAT AS A BIOMARKER TO ASSESSTHE RISK OF CANCER
SHORT TELOMERES HAVE BEEN SHOWN TO BE ARISK FACTOR FOR CERTAIN TYPES OF CANCER
BREAST
OVARIAN
UTERINE
PROSTATE
SKIN CANCERS
Recent study by Harvard / Northwestern University suggest that telomere changesmay predict cancer
DID YOU KNOW...SHORT TELOMERES IN PATIENTS WITH BRCA1/2 HAVE BEEN
RELATED WITH BREAST CANCER DEVELOPMENT AT YOUNGER
AGE THAN THOSE WITH LONGER TELOMERES
TELOMERE ANALYSISWILL HELP DETECT HIGHRISK INDIVIDUALS WITHSHORT TELOMERES MORE FREQUENTCHECKUPS AT AN
EARLIER AGE
IT IS SCIENTIFICTLYPROVEN THAT
INDIVIDUALS WITH SHORTTELOMERES HAVE HIGHER
PROBABILITY OFDEVELOPING SECONDARY
CANCERS
SHORT TELOMERES CORRELATE WITH INCREASEDCANCER INCIDENCE AND MORTALITY